Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

Reproductive hormones stories

Sep 9, 2026

New research highlights benefits and risks of hormone therapy for menopause symptoms

Multiple studies released this week show hormone therapy during menopause may reduce heart disease risk and improve mood symptoms, while supplements marketed for menopause lack evidence and contain inconsistent doses. The research comes amid growing attention to the economic costs of menopause symptoms for women.

Sep 9, 2026·5 sources
00
Aug 14, 2026

Women taking estrogen-only hormone therapy showed fewer Alzheimer's signs in brain tissue

A large study of over 2,000 women found those who used estrogen-only hormone therapy later in life were less likely to develop dementia and showed fewer signs of Alzheimer's disease in their brains upon autopsy.

Aug 14, 2026·3 sources
00
Jul 29, 2026

FDA Approves Gwyn Lo, First Once-Weekly Low-Dose Estrogen Birth Control Patch

The FDA has approved Gwyn Lo (Viatris), a new contraceptive patch that delivers norelgestromin and low-dose estrogen hormones through once-weekly administration for pregnancy prevention.

Jul 29, 2026·1 source
00
Jun 17, 2026

US Faces Progesterone Shortages as Demand for Menopause and Fertility Treatments Increases

Healthcare providers and patients across the United States are reporting intermittent shortages of oral progesterone, a hormone widely used in fertility and menopause treatments. The supply strain reflects growing demand for hormone replacement therapy.

Jun 17, 2026·3 sources
00
Apr 11, 2026

Estrogen Patch Shortages Reported Due to Surging Demand for Menopause Treatment

Growing demand for estrogen patches to relieve menopause symptoms has led to widespread shortages across pharmacies, forcing women to search multiple locations or switch medications.

Apr 11, 2026·1 source
00

Top claims

  • ▪The SWAN study researchers noted that their observational findings do not support using hormone therapy for cardiovascular disease prevention and should not guide clinical practice
  • ▪Systemic hormone therapy is FDA-approved for treating vasomotor symptoms, genitourinary syndrome, and osteoporosis prevention, but it is not FDA-approved for treating mood-related symptoms
  • ▪The Menopause Foundation of Canada estimates that menopause costs the Canadian economy $3.5 billion annually, including $237 million in lost productivity and $3.3 billion in lost income for women

Subtopics

Reproductive Health5Women's reproductive health & fertility5Menopause hormone therapy and symptom management4Age related cognitive decline2Drug Approval and Clinical Trials2Drug Policy, Pricing & Approval2Hormone therapy2Longevity & biohacking2Supplement regulation2Women’s health2Aging (Biology)1Alzheimer’s & dementia1Alzheimer's disease1Brain longevity1Cardiovascular health.1Cognitive decline1Contraception & birth control access1Evidence based supplementation1Fertility treatment access1Mental Health & Wellbeing1Neurodiversity & Cognitive Function1Pharmaceutical supply chain1Public healthcare1Women's health1

Related timelines

Congress

110 stories

Crypto hacks

100 stories

Iran War

209 stories

Strait of Hormuz blockage

148 stories

Trump administration

161 stories